Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Lung Cancer

Free Subscription Articles published in Genes Chromosomes Cancer Retrieve available abstracts of 6 articles: HTML format

Single Articles

October 2022
1. DERMAWAN JK, Torrence D, Lee CH, Villafania L, et al
   EWSR1::YY1 fusion positive peritoneal epithelioid mesothelioma harbors mesothelioma epigenetic signature: Report of 3 cases in support of an emerging entity.
   Genes Chromosomes Cancer. 2022;61:592-602.
   PubMed     Abstract available
   
   
   April 2022
2. WANG W, Gu X, Si J, Pu X, et al
   Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: a multicenter retrospective study.
   Genes Chromosomes Cancer. 2022 Apr 8. doi: 10.1002/gcc.23043.
   PubMed     Abstract available
   
   
   
3. EL ZEIN S, Djeroudi L, Reynaud S, Guillemot D, et al
   Novel EWSR1::UBP1 fusion expands the spectrum of spindle cell rhabdomyosarcomas.
   Genes Chromosomes Cancer. 2022;61:200-205.
   PubMed     Abstract available
   
   
   January 2022
4. KAZDAL D, Hofman V, Christopoulos P, Ilie M, et al
   Fusion-positive non-small cell lung carcinoma: Biological principles, clinical practice and diagnostic implications.
   Genes Chromosomes Cancer. 2022 Jan 8. doi: 10.1002/gcc.23022.
   PubMed     Abstract available
   
   
   October 2021
5. KANG J, Deng QM, Peng KC, Li P, et al
   Clinicopathological features and resistance mechanism in HIP1-ALK-rearranged lung cancer: A multicenter study.
   Genes Chromosomes Cancer. 2021 Oct 23. doi: 10.1002/gcc.23005.
   PubMed     Abstract available
   
   
   February 2021
6. PTAKOVA N, Martinek P, Holubec L, Janovsky V, et al
   Identification of tumors with NRG1 rearrangement, including a novel putative pathogenic UNC5D-NRG1 gene fusion in prostate cancer by data-drilling a de-identified tumor database.
   Genes Chromosomes Cancer. 2021 Feb 13. doi: 10.1002/gcc.22942.
   PubMed     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: